SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Jack London — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJack London
Date of birth1876-01-12
IdentifiersMRN HR-ET010-SYN-TD; SSN (made up) 000-10-4482
Document date1915-09-15
AuthorEleanor Whitcombe-Ibe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review. [S]

History of Present Illness

Mr. London has not had a drink since the evening two weeks ago when he sprained his ankle and drank two large whiskies for the pain; he talked that evening through with his counselor and has set a plan for pain and late afternoons. He takes naltrexone every morning without nausea. The ankle is much better with the brace and he has stopped the gel. He writes every morning and swims at the hour he used to take his first drink. He takes losartan 50 mg without dizziness; his home readings average 136/86. He is sleeping six hours. He has had no opioid or anti-inflammatory medicine. His hepatitis B, hepatitis C and HIV tests were negative. [S]

ElementDetail
AlcoholOne evening two weeks ago; none since
PEth36 ng/mL, from 410
KidneysCreatinine 1.96 mg/dL, eGFR 44; potassium 4.8; urine albumin 128 mg/g
Liver testsAST 34, ALT 29, GGT 82 U/L
Vitamin D24 ng/mL
MoodPHQ-9 5, item 9 scored 0

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better in the afternoons
CardiovascularNegativeNo ankle swelling
MusculoskeletalPositiveRight ankle slightly sore after a long walk
PsychiatricNegativeMood steadier; cravings in the late afternoon, less strong; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intakeOne tablet by mouth twice a day, self-directedOral route1913-08-01 to 1915-08-04stoppedS
Losartan 50 mg oral tablet once dailyOne tablet by mouth every morningOral route1915-08-04 to 1915-09-15completedS
Losartan 100 mg oral tablet once dailyOne tablet by mouth every morningOral route1915-09-15activeS
Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone checkUp to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or drivingOral route1915-08-04 to 1915-08-08completedS
Thiamine 100 mg oral tablet once dailyOne tablet by mouth dailyOral route1915-08-04activeS
Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxenOne to two tablets by mouth every six hours as needed; no more than four tablets a dayOral route1915-08-04activeS
Naltrexone 50 mg oral tablet once daily, with a wallet card warning that it blocks opioid pain medicinesOne tablet by mouth every morningOral route1915-08-18activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once dailyOne tablet by mouth dailyOral route1915-09-15activeS
Diclofenac 1% gel, 4 g rubbed into the outer right ankle four times a day for up to seven days, in place of any oral anti-inflammatory medicineApply 4 g to the ankle four times a day for up to seven daysTopical route1915-09-01 to 1915-09-08completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1915-09-15Body height173cmS
1915-09-15Body weight82.6kgS
1915-09-15Body mass index (BMI) [Ratio]27.6kg/m2S
1915-09-15Systolic blood pressure138mm[Hg]S
1915-09-15Diastolic blood pressure86mm[Hg]S
1915-09-15Heart rate78/minS
1915-09-15Respiratory rate14/minS
1915-09-15Body temperature36.6CelS
1915-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-09-15Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1915-09-15Potassium [Moles/volume] in Serum or Plasma4.8mmol/L3.5-5.1 mmol/LNormalS
1915-09-15Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
1915-09-15Creatinine [Mass/volume] in Serum or Plasma1.96mg/dL0.74-1.35 mg/dLHighS
1915-09-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M44mL/min/{1.73_m2}45 to 59 is G3a; 30 to 44 is G3bLowS
1915-09-15Albumin/Creatinine [Mass Ratio] in Urine128mg/gBelow 30 mg/g A1; 30 to 300 A2; above 300 A3HighS
1915-09-15Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma34U/L10-40 U/LNormalS
1915-09-15Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma29U/L9-46 U/LNormalS
1915-09-15Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma82U/L8-61 U/LHighS
1915-09-15Phosphatidylethanol [Mass/volume] in Blood36ng/mLBelow 20 ng/mL abstinence or light drinking; above 200 heavy drinkingHighS
1915-09-1525-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma24ng/mLBelow 20 ng/mL deficient; 20 to 29 insufficientLowS
1915-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S

Physical Exam

Vital signs recorded on 1915-09-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 138/86, pulse 78; weight 82.6 kg
CardiovascularRegular rhythm; no edema
MusculoskeletalRight ankle: slight swelling, mild tenderness over the anterior talofibular ligament; walks normally

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultationresolvedconfirmed R94.4S — Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease.
Chronic kidney disease, stage G3b A2 (eGFR 42 to 43, urine albumin 240 mg/g), most likely from hypertension with a contribution from two years of daily naproxen; kidneys of normal size, without stones or obstruction; urine sediment bland; synthetic modern diagnosis linked to his documented kidney diseaseactiveconfirmed N18.32S — Synthetic modern diagnosis made at the consultation, anchored to his documented kidney damage and death from uraemia; the cause in the modern episode is synthetic and is not a claim about his real kidneys.
Hypertensive chronic kidney disease, untreated until intakeactiveconfirmed I12.9S — Synthetic modern diagnosis made at the consultation.
Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mLactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking.
Alcohol-associated fatty liver without advanced fibrosis (liver stiffness 7.2 kPa; steatosis on ultrasound); FIB-4 2.28 at intakeactiveconfirmed K70.0S — Synthetic finding of the ultrasound and elastography at the consultation; not a claim about his real liver.
Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its placeresolvedconfirmed Z79.1S — Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis.
Cigarette smoking, about ten a day; not ready to stop while he stops drinkingactiveconfirmed F17.210S — Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim.
Right ankle sprain (lateral ligaments, moderate), from stepping into a burrow while walking the pasture; Ottawa ankle rules negative; healed in about four weeksactiveconfirmed S93.401AS — Synthetic acute injury; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationStandardized office blood pressure (five minutes' rest, validated device, average of readings)Every visitCompleted today138/86 mmHg; home average 136/86
LaboratoryPotassium and creatinine after starting or changing losartan or an SGLT2 inhibitorTwo to four weeks after each start or changeCompleted todaySix weeks on losartan 50 mg: potassium 4.8 mmol/L, creatinine 1.96 mg/dL; recheck four weeks after today's increase
LaboratoryCreatinine with eGFR and urine albumin-to-creatinine ratioG3b A2: twice a year, and at each medicine checkCompleted todayeGFR 44; urine albumin 128 mg/g, down by about half
LaboratoryElectrolytes and bicarbonateWith each kidney testCompleted todaySodium 140; bicarbonate 23 mmol/L
Laboratory25-hydroxyvitamin DAt baselineCompleted today24 ng/mL, insufficient; the test deferred from intake; vitamin D3 started
Medication safetyMedication reconciliation: no NSAIDs, kidney dosing, contrast safetyEvery visitCompleted todayNo oral NSAIDs; topical diclofenac for the sprain finished; acetaminophen within limits
Self-managementLifestyle: sodium below 2 g a day, activity, diet, weightEvery visitCompleted todayLess salt; swimming most days
SurveyDrinking since the last visit (self-report)Every visitCompleted todayOne evening two weeks ago; none since
LaboratoryPEthAt baseline and every four to six weeks in early recoveryCompleted today36 ng/mL, from 410
LaboratoryLiver tests (AST, ALT, GGT) on naltrexoneAt baseline, at four to six weeks, then every few monthsCompleted todayAST 34, ALT 29, GGT 82 U/L at four weeks of naltrexone
Medication safetyNaltrexone safety: opioid use, nausea, wallet cardEvery visitCompleted todayNo nausea; no opioid; he declined to ask for one for the sprain
ReferralAddiction-focused counseling and mutual helpWeekly in early recoveryCompleted todayFour sessions; a plan for pain and late afternoons
SurveyPHQ-9 and GAD-7At intake and at follow-upCompleted todayPHQ-9 5, from 9; item 9 scored 0
SurveySuicide-risk review, firearms storage, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; firearms locked; 988 card carried
Self-managementTobacco use and readiness to stopEvery visitCompleted todayAbout ten a day; will discuss at the preventive visit

Goal progress:

Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension and depression monographs (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2019); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Preventive visit in two weeks. Ten-week review with potassium, creatinine and PEth. Counseling weekly. The clinic or 988 at any hour. Next scheduled visit 1915-09-29: periodic adult preventive visit. [S]